Epalrestat
Product Specifications
CAS Number
82159-09-9
Target
Reductase
Related Pathways
Endocrinology/Hormones, Metabolism
Purity
0.9954
Bioactivity
Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic neuropathy and delay the progression of the disease, particularly in patients with limited microangiopathy and good glycemic control.
Smiles
CC(=C/C1=CC=CC=C1)\C=C1/SC(=S)N(CC(O)=O)C1=O
Molecular Formula
C15H13NO3S2
Molecular Weight
319.4
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TFC82796-01 50 mg
Methyl 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1,3-thiazole-2-carboxylate
Sign In for Pricing
View Details TFC82796-02 0.5 g
Methyl 5- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -1,3-thiazole-2-carboxylate
Sign In for Pricing
View Details